Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ágnes Pocskay"'
Autor:
Éva Áy, Viktor Müller, Mária Mezei, Ágnes Pocskay, Anita Koroknai, Dalma Müller, Zoltán Győri, Márta Marschalkó, Béla Tóth, Sarolta Kárpáti, Botond Lakatos, János Szlávik, Mária Takács, János Minárovits
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 20, Iss , Pp 124-130 (2020)
Objectives: Transmitted human immunodeficiency virus type 1 (HIV-1) drug resistance (TDR) may affect the success of first-line antiretroviral treatment. This study aimed to monitor the presence of HIV-1 strains carrying transmitted drug resistance-as
Externí odkaz:
https://doaj.org/article/750d697715474280a440e5ad66f5cfc2
Autor:
Mária Mezei, Dalma Müller, Janos Minarovits, János Szlávik, Márta Marschalkó, Zoltán Győri, Ágnes Pocskay, Béla E. Tóth, Viktor Müller, Sarolta Kárpáti, Anita Koroknai, Botond Lakatos, Eva Ay, Mária Takács
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 20, Iss, Pp 124-130 (2020)
Objectives Transmitted human immunodeficiency virus type 1 (HIV-1) drug resistance (TDR) may affect the success of first-line antiretroviral treatment. This study aimed to monitor the presence of HIV-1 strains carrying transmitted drug resistance-ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a39487a9944f26fa9ca5bbc5d385083f
https://doi.org/10.1016/j.jgar.2019.07.014
https://doi.org/10.1016/j.jgar.2019.07.014
Publikováno v:
Acta microbiologica et immunologica Hungarica. 68(2)
Widespread introduction of HIV integrase inhibitors into clinical care may result in appearance of drug resistance mutations affecting treatment outcome. The aim of our study was to monitor the resistance patterns of integrase inhibitors beside prote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7f65835057119fd278e0944baa6e157
https://pubmed.ncbi.nlm.nih.gov/34125695
https://pubmed.ncbi.nlm.nih.gov/34125695